Prospective study of serological conversion as a risk factor for development of leprosy among household contacts

被引:70
作者
Douglas, JT
Cellona, RV
Fajardo, TT
Abalos, RM
Balagon, MVF
Klatser, PR
机构
[1] Univ Hawaii, Dept Microbiol, Honolulu, HI 96822 USA
[2] Leonard Wood Mem Ctr Leprosy Res, Clin Lab Branch, Cebu, Philippines
[3] Royal Trop Inst, Koninklijk Inst Tropen, KIT Biomed Res, NL-1105 AZ Amsterdam, Netherlands
关键词
D O I
10.1128/CDLI.11.5.897-900.2004
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Although the prevalence of leprosy has declined over the years, there is no evidence that incidence rates are failing. A method of early detection of those people prone to develop the most infectious form of leprosy would contribute to breaking the chain of transmission. Prophylactic treatment of serologically identified high-risk contacts of incident patients should be an operationally feasible approach for routine control programs. In addition, classification of high-risk household contacts will allow control program resources to be more focused. In this prospective study, we examined the ability of serology used for the detection of antibodies to phenolic glycolipid I of Mycobacterium leprae to identify those household contacts of multibacillary leprosy patients who had the highest risk of developing leprosy. After the start of multidrug therapy for the index case, a new case of leprosy developed in one in seven of the 178 households studied. In households where new cases appeared, the seropositivity rates were significantly higher (P < 0.001) than those in households without new cases. Seropositive household contacts had a significantly higher risk of developing leprosy (relative hazard adjusted for age and sex [aRH], 7.2), notably multibacillary leprosy (aRH = 24), than seronegative contacts.
引用
收藏
页码:897 / 900
页数:4
相关论文
共 17 条
[1]   Simple and fast lateral flow test for classification of leprosy patients and identification of contacts with high risk of developing leprosy [J].
Bührer-Sékula, S ;
Smits, HL ;
Gussenhoven, GC ;
van Leeuwen, J ;
Amador, S ;
Fujiwara, T ;
Klatser, PR ;
Oskam, L .
JOURNAL OF CLINICAL MICROBIOLOGY, 2003, 41 (05) :1991-1995
[2]   Dipstick assay to identify leprosy patients who have an increased risk of relapse [J].
Bührer-Sékula, S ;
Cunha, MGS ;
Foss, NT ;
Oskam, L ;
Faber, WR ;
Klatser, PR .
TROPICAL MEDICINE & INTERNATIONAL HEALTH, 2001, 6 (04) :317-323
[3]  
CELLONA RV, 1993, INT J LEPROSY, V61, P192
[4]  
CHANTEAU S, 1993, INT J LEPROSY, V61, P533
[5]  
DAVEY TF, 1974, LEPROSY REV, V45, P121
[6]  
DOUGLAS JT, 1987, INT J LEPROSY, V55, P718
[7]  
DOUGLAS JT, 1989, LEPROSY REV, V60, P8
[8]  
Fine PEM, 1997, AM J EPIDEMIOL, V146, P91, DOI 10.1093/oxfordjournals.aje.a009195
[9]  
HOPKINS JW, 1988, J DEV AREAS, V22, P321
[10]  
KLATSER PR, 1989, LEPROSY REV, V60, P178